Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adjunct Targeted Temperature Management in Acute Severe Carbon Monoxide Poisoning
Sponsor: Wonju Severance Christian Hospital
Summary
This randomized trial will investigate important neurocognitive clinical outcomes of patients with acute severe carbon monoxide poisoning (ASCOP) randomized to receive either therapeutic hypothermia or normothermia combined with hyperbaric oxygen therapy (HBO).
Official title: Targeted Temperature Management Combined With Hyperbaric Oxygen Therapy in Acute Severe Carbon Monoxide Poisoning: Multicenter Randomized Controlled Clinical Trial (TTM-COHB Trial)
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
46
Start Date
2021-10-25
Completion Date
2025-12-31
Last Updated
2025-08-15
Healthy Volunteers
No
Interventions
Targeted therapeutic hypothermia
Targeted therapeutic hypothermia is then performed at a body temperature of 33±0.5 °C during 24 h using a surface cooling device as soon as possible after the HBO and research consent. After TH ended, rewarming is done slowly between 0.2℃ - 0.5℃/h for 12 hours. After rewarming, it will be held at 36.5 ℃ for 36 hours.
Targeted therapeutic normothermia
Targeted therapeutic normothermia will be held at 36.5±0.5 ℃ for 72 hours using a surface cooling device after the HBO and research consent.
Locations (2)
Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, South Korea
Inha University Hospital
Incheon, Incheon, South Korea